April 2, 2026

Science Chronicle

A Science and Technology Blog

April 2, 2026

Science Chronicle

A Science and Technology Blog

Author: Prasad Ravindranath

CoronavirusHealthIndiaPublic HealthSARS-CoV-2

Over 50% coronavirus cases, deaths are from five Indian cities

Nearly 51% coronavirus cases and over 53% deaths in India were from just five cities — Mumbai, Delhi, Ahmedabad, Chennai,

Read More
CDCCoronavirusHealthMERSPublic HealthSARS-CoV-2

Coronavirus: Fewer infected people account for larger virus spread

Three studies have found that a small percentage of people who have been infected with novel coronavirus account for a

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2

Hydroxychloroquine does not prevent deaths, RECOVERY trial finds

The RECOVERY trial, a large randomised controlled trial in the UK to test five drugs, found that hydroxychloroquine drug did

Read More
CoronavirusHealthPredatory JournalsPublic HealthSARS-CoV-2

‘Paper’ in predatory journal by health ministry claims COVID-19 in India will end by mid-September

A “paper” by two health ministry researchers claiming that COVID-19 in India will end by mid-September has been published in

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2

Remdesivir trial results: NEJM, NIAID and Gilead provide conflicting information

Information shared by the three stakeholders — NEJM, NIAID and Gilead — on critical issues about whether the drug’s ability

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2Vaccines

Phase-1 trial: Adenovirus COVID-19 vaccine found safe, induces immune responses

A phase-1 trial using a single dose of a vaccine (Ad5-nCoV) that uses a recombinant adenovirus type-5 vector that carries

Read More
Animal trialsClinical trialCoronavirusHealthHerd immunityPublic HealthSARS-CoV-2Vaccines

Monkeys resist coronavirus reinfection; six DNA vaccines show promise in animal studies

Six rhesus macaque monkeys were resistant to reinfection following exposure to novel coronavirus. Compared with nose, the lungs had very

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2

Recovery Trial for COVID-19 to test five drugs

The Recovery Trial will test five already approved drugs — HIV drug Lopinavir-Ritonavir,  anti-inflammatory corticosteroid (dexamethasone), anti-malaria drug hydroxychloroquine and

Read More
ChinaCoronavirusHealthPublic HealthSARS-CoV-2World Health Organisation

Faeces samples can harbour infectious coronavirus, study finds

Chinese researchers were able to isolate and culture novel coronavirus from faeces samples. Confirmation of infectious virus in faeces samples

Read More
CoronavirusHealthPublic HealthSARS-CoV-2Vaccines

Moderna’s coronavirus vaccine is safe, interim results of phase-1 trial shows

Interim results of Moderna’s phase-1 human clinical trial of novel coronavirus vaccine (mRNA-1273) shows the vaccine is safe. The vaccine

Read More
ChinaCoronavirusHealthIndiaPublic HealthSARS-CoV-2

COVID-19: India surpasses China’s tally despite prolonged lockdown

On May 15, 106 days after the first novel coronavirus case was reported on January 30, with over 85,500 cases,

Read More
Clinical trialCoronavirusFDAHealthHuman challenge studiesNIHPublic HealthSARS-CoV-2VaccinesWorld Health Organisation

WHO backs COVID-19 vaccine trials that deliberately infect participants

In new guidelines issued on May 6, WHO has backed human challenge studies for COVID-19 vaccines on the ground that

Read More
CoronavirusHealthHerd immunityPublic HealthSARS-CoV-2World Health Organisation

COVID-19: Aiming to achieve herd immunity naturally is ‘dangerous’, WHO warns

It was mistakenly assumed that as this disease spreads across the world, only the severe cases become apparent while most

Read More